Skip to main content
Early TNBC: Durvalumab+NACT improves survival despite modest pCR increase
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Early TNBC: Durvalumab+NACT improves survival despite modest pCR increase
User login
Username
Password
Reset your password
Concept
Lead
score
Breast Cancer
1
1
Biologic Therapy for Cancer
0
0.75
Triple Negative Breast Cancer
0
0.59
Breast
0
0.34
Cancer
0
0.34
Neoadjuvant Therapy
0
0.55
Chemotherapy
0
0.17
Specialty
Lead
score
Hematology-Oncology
1
1
Ob/Gyn & Women's Health
0
0.69
Edit Tags